ReShape Lifesciences, Inc. (RSLS) Q1 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Vyome Holdings, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:04.191 Good afternoon, and thank you for joining the Reshape Life Sciences first quarter 2023 00:00:04.191 -- 00:00:11.073 conference call. I would like to turn the call over to Michael Miller from RX Communications. 00:00:11.694 -- 00:00:15.356 Good afternoon, and thank you for joining the Reshape Life Sciences first quarter 2023 00:00:15.356 -- 00:00:20.458 earnings call. I'm pleased to be joined today by Paul Hickey, President and Chief 00:00:20.458 -- 00:00:25.000 Executive Officer, and Tom Stankovich, Chief Financial Officer. 00:00:25.000 -- 00:00:29.900 Paul will provide an overview and update on the company's activities and Tom will review 00:00:29.900 -- 00:00:34.402 the financial results for the period. He will then turn the call back over to Paul for 00:00:34.402 -- 00:00:39.524 some closing remarks, after which we'll open the call to a question and answer session. 00:00:39.524 -- 00:00:44.546 As a reminder, this conference call, as well as Reshape Life Sciences' SEC 00:00:44.546 -- 00:00:49.648 filings and website, including the investor information section of the website, contains 00:00:49.648 -- 00:00:54.590 forward-looking statements within the meaning of the Private Securities Litigation Reform 00:00:54.590 -- 00:00:56.613 Act of 1995. 00:00:56.613 -- 00:01:01.795 Actual results could differ materially from those discussed due to known and unknown 00:01:01.795 -- 00:01:07.197 risks, uncertainties, and other factors. These and additional risks and uncertainties 00:01:07.197 -- 00:01:12.059 are described more fully in the company's filings with the Securities Exchange Commission, 00:01:12.059 -- 00:01:17.441 including those factors identified as risk factors in the company's most recent 00:01:17.441 -- 00:01:20.203 annual rep...